Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse
暂无分享,去创建一个
[1] M. Atkinson,et al. Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy , 1990, Diabetes.
[2] H. Binz,et al. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Bedossa,et al. Syngeneic t cell transfer of diabetes into nod newborn mice: in situ studies of the autoimmune steps leading to insulin‐producing cell destruction , 1989, European journal of immunology.
[4] N. Simpson,et al. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.
[5] P. Chatelain,et al. Islet cell and insulin autoantibodies in subjects at high risk for development of Type 1 (insulin-dependent) diabetes mellitus: the Lyon family study , 1988, Diabetologia.
[6] E. Leiter,et al. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. , 1988, Journal of immunology.
[7] J. Rygaard,et al. Antigen expression of the pancreatic beta‐cells is dependent on their functional state, as shown by a specific, BB rat monoclonal autoantibody IC2 , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[8] J. Levy,et al. Nutrition and autoimmunity: a review. , 1986, Clinical and experimental immunology.
[9] L. Wicker,et al. Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice , 1986, Diabetes.
[10] G. Karsenty,et al. CYCLOSPORIN INCREASES THE RATE AND LENGTH OF REMISSIONS IN INSULIN-DEPENDENT DIABETES OF RECENT ONSET Results of a Multicentre Double-blind Trial , 1986, The Lancet.
[11] P. Hunt,et al. Suppressive effects of insulin and insulin-like growth factor-1 (IGF1) on immune responses. , 1986, Journal of immunology.
[12] G. Eisenbarth. Type I diabetes mellitus. A chronic autoimmune disease. , 1986 .
[13] M. Nishida,et al. New Diabetogenic Streptozocin Analogue, 3-O-Methyl-2-{[(methylnitrosoamino) carbonyl]amino}-D-glucopyranose: Evidence for a Glucose Recognition Site on Pancreatic B-Cells , 1986, Diabetes.
[14] K. Buschard,et al. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals , 1985, Diabetologia.
[15] M. Marcelli,et al. Influence of a transplantable insulinoma on the pancreatic status of insulin and pancreatic polypeptide in the rat , 1985, Diabetologia.
[16] K. A. Wall,et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.
[17] J. McNally,et al. EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS , 1981, The Lancet.
[18] J. Helderman. Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. , 1981, The Journal of clinical investigation.
[19] Y. Tochino,et al. Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.
[20] L. Herzenberg,et al. Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens * , 1979, Immunological reviews.
[21] J. Mirouze,et al. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas , 1978, Diabetologia.
[22] P. Davoren. The isolation of insulin from a single cat pancreas. , 1962, Biochimica et biophysica acta.
[23] G. Bottazzo,et al. Islet-cell and insulin autoantibodies in diabetes , 1987 .